We have observed
12 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after November 30, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
PROCATHEPSIN L AND CATHEPSIN L AS BIOMARKERS FOR ISCHEMIA
Quantification of a functionalized surface
A method for filtering a biological sample
Heater for a disposable dignostics cartridge
Method and device for performing biological and/or chemical assays
Method for injecting microparticles into a microfluidic channel
IMPROVED ENCODED MACROCARRIERS, ASSAY SYSTEM USING THEM AND METHOD FOR PERFORMING AN ASSAY
Method for producing microcarriers and for performing biological assays
Method for producing structured microcarriers
Method for producing microcarriers
LTBP2 AS A BIOMARKER FOR PREDICTING OR PROGNOSTICATING MORTALITY